You can buy or sell KOD and other stocks, options, ETFs, and crypto commission-free!
Kodiak Sciences Inc Common Stock, also called Kodiak Sciences, is a a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline include KSI-301 for wet AMD; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD; and KSI-401 for dry AMD. Read More The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.
Palo Alto, California
52 Week High
52 Week Low
Expected Nov 14, Pre-Market